RU2015146979A - Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена - Google Patents
Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена Download PDFInfo
- Publication number
- RU2015146979A RU2015146979A RU2015146979A RU2015146979A RU2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A RU 2015146979 A RU2015146979 A RU 2015146979A
- Authority
- RU
- Russia
- Prior art keywords
- lactic acid
- strain
- acid bacteria
- medicine according
- rhamnosus cncm
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims 14
- 235000014655 lactic acid Nutrition 0.000 title claims 7
- 239000004310 lactic acid Substances 0.000 title claims 7
- 230000037356 lipid metabolism Effects 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims 7
- 241000894006 Bacteria Species 0.000 claims 6
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims 6
- 230000001575 pathological effect Effects 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010033307 Overweight Diseases 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
Claims (6)
1. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства для предотвращения или лечения патологического состояния, являющегося результатом избыточного накопления жировой ткани и/или резистентности к инсулину.
2. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 1, отличающееся тем, что указанное патологическое состояние выбрано из избыточного веса, ожирения и болезней, являющихся их результатом.
3. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по любому из пп. 1 и 2, отличающееся тем, что указанный медикамент создан для перорального введения.
4. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 1 или 2, отличающееся тем, что указанный штамм содержится в композиции для перорального введения.
5. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 4, отличающееся тем, что указанная композиция представляет собой продукт питания или пищевую добавку.
6. Применение штамма молочнокислой бактерии rhamnosus CNCM I-4317 в качестве лекарственного средства по п. 4, отличающееся тем, что указанная композиция представляет собой молочный продукт.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1353600A FR3004621B1 (fr) | 2013-04-19 | 2013-04-19 | Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique |
| FR1353600 | 2013-04-19 | ||
| PCT/IB2014/060841 WO2014170879A1 (fr) | 2013-04-19 | 2014-04-18 | Souche de lactobacillus rhamnosus régulatrice du métabolisme lipidique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015146979A true RU2015146979A (ru) | 2017-05-24 |
Family
ID=49003844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015146979A RU2015146979A (ru) | 2013-04-19 | 2014-04-18 | Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160074444A1 (ru) |
| EP (1) | EP3027061A1 (ru) |
| FR (1) | FR3004621B1 (ru) |
| MX (1) | MX2015014450A (ru) |
| RU (1) | RU2015146979A (ru) |
| WO (1) | WO2014170879A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113046276B (zh) * | 2021-04-30 | 2022-03-18 | 澳优乳业（中国）有限公司 | 一种母乳源鼠李糖乳杆菌及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7001756B1 (en) * | 2004-02-19 | 2006-02-21 | Genmont Biotech Inc. | Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity |
| KR100686557B1 (ko) * | 2004-08-16 | 2007-02-23 | 씨제이 주식회사 | 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품 |
| EP2022502A1 (en) * | 2007-08-10 | 2009-02-11 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
| EP2216035A1 (en) * | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus rhamnosus CNCM I-4096 and weight control |
| FI123157B (fi) * | 2009-05-12 | 2012-11-30 | Valio Oy | Probioottien uusi käyttö |
| WO2011148219A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
-
2013
- 2013-04-19 FR FR1353600A patent/FR3004621B1/fr active Active
-
2014
- 2014-04-18 MX MX2015014450A patent/MX2015014450A/es unknown
- 2014-04-18 EP EP14722774.8A patent/EP3027061A1/fr not_active Withdrawn
- 2014-04-18 RU RU2015146979A patent/RU2015146979A/ru not_active Application Discontinuation
- 2014-04-18 US US14/784,760 patent/US20160074444A1/en not_active Abandoned
- 2014-04-18 WO PCT/IB2014/060841 patent/WO2014170879A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| FR3004621B1 (fr) | 2015-05-15 |
| WO2014170879A1 (fr) | 2014-10-23 |
| EP3027061A1 (fr) | 2016-06-08 |
| FR3004621A1 (fr) | 2014-10-24 |
| US20160074444A1 (en) | 2016-03-17 |
| MX2015014450A (es) | 2016-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500169A1 (en) | Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders | |
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| NZ745678A (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
| RU2015129066A (ru) | Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности | |
| NZ612455A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
| BR112014008511A2 (pt) | composições nutricionais com fitonutrientes | |
| JP2015523321A5 (ru) | ||
| NZ601141A (en) | Nutritional formulas containing synbiotics | |
| IN2014KN02830A (ru) | ||
| BR112013028709A2 (pt) | cepas bacterianas capazes de metabolizar oxalatos | |
| MY191803A (en) | Personalized pediatric nutrition products comprising human milk oligosaccharides | |
| RU2015122748A (ru) | Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности | |
| JP2017515499A5 (ru) | ||
| JP2015533509A5 (ru) | ||
| BRPI0811347A2 (pt) | "extrato herbáceo medicinal dotado de efeito antiobesidade" | |
| RU2015122728A (ru) | Штамм lactobacillus rhamnosus для уменьшения накопления жира в организме | |
| EP3612570A4 (en) | POLYMER MATERIALS FOR DELIVERING SHORT CHAIN FATTY ACIDS TO THE INTESTINAL FOR HUMAN HEALTH APPLICATIONS AND DISEASE TREATMENT | |
| WO2018093237A3 (ko) | 포름산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
| RU2015146979A (ru) | Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена | |
| WO2016008642A3 (en) | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions | |
| BR112016017765A8 (pt) | composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso | |
| ATE536102T1 (de) | Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus | |
| BR112019008370A2 (pt) | composição para tratamento preventivo ou curativo de distúrbios hepáticos | |
| Zhou et al. | OBSERVATION ON THE THERAPEUTIC EFFECT OF AURICULAR POINT STICKING ON SIMPLE OBESITY | |
| Hsieh et al. | Novel Concepts to Develop an" All-in-One" Functional Food for Health and Disease Prevention in the 21~(st) Century by Biomarkers Technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180418 |